Jun 8, 2024, 10:07
Ari Rosenberg: Our OPTIMA II trial is out in JAMA Oncology
Ari Rosenberg, Medical Oncologist and Assistant Professor at the University of Chicago, shared a post on X: ,
“Excited that our OPTIMA II trial is out in JAMA Oncology!
Neoadjuvant nivolumab/chemotherapy -> response-adaptive treatment for HPV+ oropharyngeal cancer.”
Proceed to the article.
Source: Ari Rosenberg/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56
Nov 13, 2024, 15:46